Fingerprint
Dive into the research topics of 'Phase i study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias
R. Tibes, K. T. McDonagh, L. Lekakis, J. M. Bogenberger, S. Kim, N. Frazer, S. Mohrland, D. Bassett, R. Garcia, K. Schroeder, V. Shanmugam, J. Carpten, R. T. Hagelstrom, C. Beaudry, D. Von Hoff, T. C. Shea
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations